Top Bone and Joint Health Supplements Companies

Bone and Joint Health Supplements Market size was valued at USD 14.63 Billion in 2024 and is poised to grow from USD 15.98 Billion in 2025 to USD 32.31 Billion by 2033, growing at a CAGR of 9.2% during the forecast period (2026–2033).

Key vendors include Amway, Nestlé Health Science, Abbott Laboratories, Pfizer Inc., Bayer AG, Glanbia plc, NOW Foods, Nature's Bounty Co., Nutramax Laboratories, Herbalife Nutrition Ltd., DSM, BASF SE, Archer Daniels Midland Company, DuPont Nutrition & Biosciences, ChromaDex Corp., Garden of Life, Thorne Research, Jamieson Laboratories, USANA Health Sciences, and MegaFood.

An aging global population is the key driver of the Bone and Joint Health Supplements Market. The growing geriatric population has increased the incidence of arthritis, osteoporosis, and other bone-related conditions, driving demand for supplements that support bone and joint health.

The key market trend in the Bone and Joint Health Supplements Market is increased awareness of preventive healthcare. Growing health and fitness consciousness is encouraging consumers, particularly aging populations, to use supplements proactively to support bone strength, joint health, and overall wellness.

North America accounted for the largest share of the Bone and Joint Health Supplements Market, driven by a growing aging population, high prevalence of bone and joint disorders, strong consumer health awareness, and increasing demand for preventive nutrition and supplements.